Skip to content

CREYOS VS. NEUROTRACK

A More Complete Solution for Behavioral Health Assessment

Objectively assess and care for dementia and other behavioral health conditions with Creyos, backed by over 30 years of research.

Trusted by Thousands of Healthcare Providers and Leading Organizations
One Medical 1-1
Oak Street Logo 1
AARP-Logo 1-1
Cedars Sinai 1-1

Fast Yet Accurate

Screen in less than 5 minutes, and automate results based on large normative database and scientific research base for exceptional accuracy.

Insurance-Friendly 

Assessments align to fee-for-service and current value-based-care insurance models, making it easier to obtain reimbursement while delivering even higher quality patient care.

Flexible Administration

Administer in-clinic or at home, on any device, by either a physician or medical assistant. Creyos integrates seamlessly and requires no special environment, lighting, or hardware to work.

All patients. All Brain Health Conditions.
One Solution. 

Unlike Neurotrack that only tests for dementia, Creyos offers a breadth of scientifically validated online protocols. Healthcare professionals using Creyos accurately and efficiently screen for dementia, but are also able to objectively test patients for depression, ADHD, concussion, fatigue, and more. Why settle for a single-purpose solution when you can have a versatile platform that reliably tests for all conditions in your patient population? 

One solution-1

Dementia Testing That Meets DSM-5 Diagnostic Criteria 

Equip your providers with the confidence to render an accurate diagnosis. Creyos tests patient cognition across the multiple cognitive domains required for dementia diagnosis according to DSM-5 criteria. It also includes digitized versions of the IADL and IQ-CODE, giving providers a more complete assessment with easy to read, actionable, reports.  

DSM-5 standard-2
 Oak Street Logo in Quote
 
We really wanted to help our Oak Street Health primary care providers understand the exact diagnostic criteria for dementia. Creyos has been a perfect fit for us because it has the objective impairment measures with both the screener and the assessment. But then also importantly to our primary care providers, there’s a questionnaire on functional decline as well. And that, of course, required for DSM-5 for dementia diagnosis.

Dr. Justin Hunt

Senior Medical Director of Behavioral Health

Oak Street Health

Developed With Unparalleled Scientific Rigor

Creyos online tasks are derived from well-established neuropsychological assessments that have been utilized for decades in research settings, ensuring reliable and objective results for clinical use. 

Published in over 400 peer-reviewed studies, compared to Neurotrack's 25, Creyos is a scientifically validated solution capable of replacing legacy testing tools like the MoCA, SLUMs, or MMSE. 

With a comprehensive normative database of 85,000 individuals, Creyos precisely validates patient performance against healthy peers within specific demographics, giving providers pinpoint accuracy for better clinical decision making. 

Scientific rigor

Inclusive Dementia Screening and Testing for all Patient Populations 

Engage your entire patient population. Creyos is available in multiple languages and features voiceover instructions, embedded tutorials, and high-contrast designs. All patients, regardless of literacy, background, or ability, can complete assessments, promoting greater health equity.

  • Multilingual: Creyos is available in multiple languages including English, Spanish, Polish, and many others, removing language barriers and ensuring patients are tested in the language they’re most comfortable with.
  • Accessible: Creyos adheres to accessibility best practices with high contrast design, suitable color palettes, and voice-over instructions, ensuring usability for patients with visual impairments or low literacy levels.
  • Engaging: Creyos tasks are designed as online games to reduce patient anxiety and boost completion rates. Infinite problem sets prevent memorization and enable accurate re-testability for longitudinal monitoring.
all population-1

Care Planning Guided by the Alzheimer’s Association

Care planning extends beyond just lifestyle recommendations and specialist referrals. With Creyos, PCPs get an online care planning tool that incorporates assessment results and enables them to provide clear instructions for medication management, therapeutic needs, and caregiver activities. That means increased patient safety, reduced healthcare costs, and better caregiver support

 

Care planning-2

Optimized Workflows to Fully Integrate Brain Health Assessment

Every Creyos customer receives a dedicated account management team to streamline the entire process, from setup and onboarding to seamless EHR integration. That means greater adoption by physicians, efficient clinical workflows, and more time spent caring for patients and greater intervention effectiveness than time spent on paperwork.

EHR systems
Backed by decades of scientific proof
pubmed

March, 2024

Visuospatial cognition predicts performance on an obstructed vision obstacle walking task in older adults

cell report medicine-1

October, 2022

Disentangling the cognitive, physical, and mental health sequelae of COVID-19

frontiers

March, 2022

Cognitive Impairment Early After Initiating Maintenance Hemodialysis: A Cross Sectional Study

Alzheimers-and-Dementia-Journal-logo

December, 2023

Poorer online cognitive performance is associated with genetic risk for Alzheimer’s disease and brain phenotypes in healthy mid-life and older adults.

Ready to see what Creyos can do for your practice or health system?

Get your personalized demo, and free trial to see how you can improve cognitive testing and care planning with Creyos.

Book a Demo